Frenova, a Fresenius Medical Care Company, provides you with the most suitable investigators and patients to achieve your enrollment goals for renal or adjacent disease trials. As a site management organization with over 25 years of experience centered on renal research and the unique needs of renal patients, we provide managed investigator sites, patients, and the data your clinical trial demands.

In the world of kidney disease and related disorders, Frenova is the largest provider of investigators, CKD patients, ESRD patients, and data assets. Exclusive access to Fresenius Medical Care’s unmatched renal expertise and global patient population facilitates rapid clinical research patient recruitment and enrollment for your trials.

And because of our unparalleled insight into renal disease and patient care, we are the trusted patient-centric authority for developing study protocols involving renal patients. Our mindful protocol design support eases study execution, boosts operational efficiency, improves patient adherence, and helps you avoid costly, time-consuming protocol revisions.

As the leading global manager of nephrology-oriented sites, Frenova gives sponsors a single, expert point of contact to manage renal-related studies. At the same time, Frenova gives investigators the help they need to successfully integrate and manage research within their nephrology practices. Our managed sites, primed for rapid site startup and superior study execution, are ideally suited to deliver the reliable performance and high-quality data you need to gain critical insights and advance the science of renal therapies.

Our F1RST Up® Site Network (USA)

550 Investigators
350 Locations
700 Dialysis Clinics

Our Global Network of Clinics (EMEA, LATAM, APAC)

1300 Clinicians
45 Countries
1300 Locations
120000 Patients

When you’re wondering how to find sites, patients, and data for your next trial, FRENOVA KNOWS.